A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data

被引:37
作者
Bonetti, Marco [1 ]
Zahrieh, David [2 ]
Cole, Bernard F. [3 ]
Gelber, Richard D. [2 ,4 ]
机构
[1] Bocconi Univ, Dept Decis Sci, I-20136 Milan, Italy
[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[3] Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA
[4] Harvard Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02115 USA
关键词
treatment-covariate interaction; clinical trials; permutation-based inference; survival analysis; NEGATIVE BREAST-CANCER; CLINICAL-TRIALS; ENDOCRINE RESPONSIVENESS; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; SUBSETS; THERAPY; WOMEN; CMF;
D O I
10.1002/sim.3524
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A new, intuitive method has recently been proposed to explore treatment-covariate interactions in survival data arising from two treatment arms of a clinical trial. The method is based on constructing overlapping subpopulations of patients with respect to one (or more) covariates of interest and in observing the pattern of the treatment effects estimated across the subpopulations. A plot of these treatment effects is called a subpopulation treatment effect pattern plot. Here, we explore the small sample characteristics of the asymptotic results associated with the method and develop an alternative permutation distribution-based approach to inference that should be preferred for smaller sample sizes. We then describe an extension of the method to the case in which the pattern of estimated quantiles of survivor functions is of interest. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:1255 / 1268
页数:14
相关论文
共 13 条
[1]   Patterns of treatment effects in subsets of patients in clinical trials [J].
Bonetti, M ;
Gelber, RD .
BIOSTATISTICS, 2004, 5 (03) :465-481
[2]  
Bonetti M, 2000, STAT MED, V19, P2595, DOI 10.1002/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO
[3]  
2-M
[4]   Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: A randomized trial [J].
Castiglione-Gertsch, M ;
O'Neill, A ;
Price, KN ;
Goldhirsch, A ;
Coates, AS ;
Colleoni, M ;
Nasi, ML ;
Bonetti, M ;
Gelber, RD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (24) :1833-1846
[5]   Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer:: role of endocrine responsiveness of the tumor [J].
Colleoni, M ;
Li, S ;
Gelber, RD ;
Coates, AS ;
Castiglione-Gertsch, M ;
Price, KN ;
Lindtner, J ;
Rudenstam, CM ;
Crivellari, D ;
Collins, J ;
Pagani, O ;
Simoncini, E ;
Thürlimann, B ;
Murray, E ;
Forbes, J ;
Erzen, D ;
Holmberg, S ;
Veronesi, A ;
Goldhirsch, A .
ANNALS OF ONCOLOGY, 2005, 16 (05) :716-725
[6]   Duration of adjuvant chemotherapy for breast cancer:: a joint analysis of two randomised trials investigating three versus six courses of CMF [J].
Colleoni, M ;
Litman, HJ ;
Castiglione-Gertsch, M ;
Sauerbrei, W ;
Gelber, RD ;
Bonetti, M ;
Coates, AS ;
Schumacher, M ;
Bastert, G ;
Rudenstam, CM ;
Schmoor, C ;
Lindtner, J ;
Collins, J ;
Thürlimann, B ;
Holmberg, SB ;
Crivellari, D ;
Beyerle, C ;
Neumann, RLA ;
Goldhirsch, A .
BRITISH JOURNAL OF CANCER, 2002, 86 (11) :1705-1714
[7]   Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of international breast cancer study group trial IV [J].
Crivellari, D ;
Price, K ;
Gelber, RD ;
Castiglione-Gertsch, M ;
Rudenstam, CM ;
Lindtner, J ;
Fey, MF ;
Senn, HJ ;
Coates, AS ;
Collins, J ;
Goldhirsch, A .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4517-4523
[8]  
Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054
[9]  
KEANEY KM, 1994, BIOMETRIKA, V81, P279, DOI 10.1093/biomet/81.2.279
[10]  
Pesarin F, 2001, Multivariate permutation tests: With applications in biostatistics